Skip to main content
OFFICIAL STATEMENT · SWITZERLAND

Official Endopeel Safety Statement

Scientific Clarification · Authenticity · Traceability · Patient Safety

Endopeel is the designation of a set of specific medical techniques, not the generic name of an injectable substance. This official statement clarifies the distinction between the original techniques, their historical formulation and preparations of unverified origin marketed under the Endopeel name.

Scientific Integrity Product Authenticity Medical Training Patient Safety
Issued by
Dr. Alain Tenenbaum, M.D., Ph.D., D.Sc.
Inventor and Developer of Endopeel Techniques
Switzerland

In 30 Seconds

Four Essential Facts Everyone Should Know
01

Techniques, Not a Generic Product

Endopeel designates a set of specific medical techniques. It is not the generic name of an injectable chemical substance.

02

The Historical Original Formulation

DocTNB was the historical formulation associated with the original techniques. Its identity cannot be established by a commercial name alone.

03

Unverified Preparations

Preparations marketed as Endopeel or Hidroxibenceno cannot be presumed equivalent to the original formulation without appropriate scientific verification.

04

Training and Patient Safety

Specific medical training, product authentication, traceability, regulatory compliance and informed consent are essential considerations for patient safety.

A shared commercial designation does not establish chemical equivalence, clinical safety or authenticity.

Endopeel Is Not a Generic Product

Understanding the Difference Between a Medical Technique and a Chemical Formulation

Endopeel was developed as a set of specific medical techniques involving muscle and skin retensioning and three-dimensional reshaping. It does not designate a generic injectable substance or a standardized pharmaceutical ingredient.

ORIGINAL MEDICAL CONCEPT

Endopeel Techniques

A specific medical approach developed by Dr. Alain Tenenbaum and Mauro Tiziani, incorporating:

  • Chemical myoplasty.
  • Chemical myopexy.
  • Chemical myotension.
  • Specific anatomical and clinical knowledge.
  • Dedicated medical education and training.
NO AUTOMATIC EQUIVALENCE

Injectable Preparations

A preparation marketed under the Endopeel name cannot automatically be identified as the original historical formulation.

  • A commercial name is not a chemical identity.
  • Similar ingredients do not establish equivalence.
  • Manufacturing origin requires verification.
  • Product authenticity requires documentation.
  • Clinical safety cannot be inferred from branding.
FUNDAMENTAL DISTINCTION

The use of the Endopeel name does not, by itself, establish the identity of an injected substance, its authenticity or conformity with the original medical techniques.

The Original DocTNB Formulation

Historical Identity · Scientific Documentation · Authenticity
Historical original DocTNB packaging from the Endopeel archives
Historical DocTNB formulation — archival documentation.
HISTORICAL REFERENCE

A Specific Historical Formulation

DocTNB was the historical formulation associated with the development of the original Endopeel techniques by Dr. Alain Tenenbaum.

Its scientific identity cannot be reduced to a generic chemical designation or established solely through the use of the Endopeel name.

According to the inventor's historical records, the original DocTNB formulation was no longer commercially available in 2019.

01

Formulation Identity

Chemical identity requires appropriate analytical documentation, including relevant stereochemical and physicochemical characteristics.

02

Historical Traceability

Authentication requires reliable manufacturing records, provenance, batch identification and supporting documentation.

03

Scientific Non-Equivalence

Experimental observations concerning DocTNB cannot automatically be extrapolated to other preparations of unverified composition.

IMPORTANT HISTORICAL CLARIFICATION

The presence of the Endopeel name on a preparation does not constitute proof that it is the original DocTNB formulation. Authenticity and clinical safety require independent verification.